Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial - 30/10/18
Doi : 10.1016/j.ahj.2018.07.010
Robert J. Mentz, MD a, b, ⁎ 
, Christopher M. O'Connor, MD a, c, Bradi B. Granger, PhD, MSN, RN d, Hongqiu Yang, PhD b, Chetan B. Patel, MD a, b, Karen E. Steinhauser, PhD a, e, Mona Fiuzat, PharmD a, Kimberly S. Johnson, MD a, b, Kevin J. Anstrom, PhD b, f, Gwen C. Dodson, MSN a, Donald H. Taylor, PhD, MPA b, g, h, Daniel B. Mark, MD a, b, James A. Tulsky, MD i, j, Joseph G. Rogers, MD a, b
, Christopher M. O'Connor, MD a, c, Bradi B. Granger, PhD, MSN, RN d, Hongqiu Yang, PhD b, Chetan B. Patel, MD a, b, Karen E. Steinhauser, PhD a, e, Mona Fiuzat, PharmD a, Kimberly S. Johnson, MD a, b, Kevin J. Anstrom, PhD b, f, Gwen C. Dodson, MSN a, Donald H. Taylor, PhD, MPA b, g, h, Daniel B. Mark, MD a, b, James A. Tulsky, MD i, j, Joseph G. Rogers, MD a, b a Department of Medicine, Duke University School of Medicine, Durham, NC
b Duke Clinical Research Institute, Durham, NC
c Inova Heart & Vascular Institute, Falls Church, VA
d Duke School of Nursing, Duke University, Durham, NC
e Center for Health Services Research and Development in Primary Care, Durham VA Medical Center, Durham, NC
f Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC
g Sanford School of Public Policy, Duke University, Durham, NC
h Duke-Margolis Center for Health Policy, Duke University, Durham, NC
i Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA
j Division of Palliative Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA
⁎Reprint requests: Robert Mentz, DCRI, PO Box 17969, Durham, NC 27715.DCRIPO Box 17969DurhamNC27715
Le texte complet de cet article est disponible en PDF.
| Larry A. Allen, MD, MHS, served as guest editor for this article. |
|
| Funding: PAL-HF was funded by the National Institute of Nursing Research (R01NR013428). R. J. M. receives research support from the NIH (U10HL110312, R01AG045551-01A1). K. J. received research support from projects funded by the NIA (RO1AG042130; K08AG028975). |
|
| Disclosures: The authors report no relevant disclosures. |
© 2018
Elsevier Inc. Tous droits réservés.
Vol 204
P. 202-204 - octobre 2018 Retour au numéro
Article précédent
- Management of cardiogenic shock in acute decompensated chronic heart failure: The ALTSHOCK phase II clinical trial
- Nuccia Morici, Fabrizio Oliva, Silvia Ajello, Miriam Stucchi, Alice Sacco, Manlio Gianni Cipriani, Michele De Bonis, Andrea Garascia, Maria Pia Gagliardone, Giulio Melisurgo, Claudio Francesco Russo, Carlo La Vecchia, Maria Frigerio, Federico Pappalardo
- Ticagrelor versus clopidogrel for recovery of vascular function immediately after successful chronic coronary total occlusion recanalization: A randomized clinical trial
- Salvatore Brugaletta, Josep Gomez-Lara, Juan Caballero, Luis Ortega-Paz, Luis Teruel, Miriam Jimenez Fernandez, Rafael Romaguera, Vicente Alcalde Martinez, Marcos Ñato, Eduardo Molina Navarro, Joan-Antoni Gomez-Hospital, Concepcion Correa Vilches, Maria Joyera, Angel Cequier, Dominick J Angiolillo, Manel Sabate
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?